Abstract
An improved synthesis of DNA-dependent protein kinase inhibitor, IC86621 is described. This developed method provides an easy access to this simple molecule by using amination, acetylation and Fries rearrangement reactions.
Article PDF
Similar content being viewed by others
References
Allen, C., Halbrook, J., and Nickoloff, J. A., Interactive competition between homologous recombination and nonhomologous end joining. Mol. Cancer Res., 1, 913–920 (2003).
Boyer, J. L., Krum, J. E., Myers, M. C., Fazal, A. N., and Wigal, C. T., Synthetic utility and mechanistic implications of the Fries Rearrangement of hydroquinone diesters in boron trifluoride complexes. J. Org. Chem., 65, 4712–4714 (2000).
Cano, C., Barbeau, O. R., Bailey, C., Cockcroft, X.-L., Curtin, N. J., Duggan, H., Frigerio, M., Golding, B. T., Hardcastle, I. R., Hummersone, M. G., Knights, C., Menear, K. A., Newell, D. R., Richardson, C. J., Smith, G. C. M., Spittle, B., and Griffin, R. J., DNA-dependent protein kinase (DNA-PK) inhibitors. Synthesis and biological activity of quinolin-4-one and pyridopyrimidin-4-one surrogates for the chromen-4-one chemotype. J. Med. Chem., 53, 8498–8507 (2010).
Clunas, S., Strory, J. M. D., Rickard, J. E., Horsley, D., Harrington, C. R., and Wischik, C. M., 3,6-Disubstituted xanthylium salts. PCT Int. Appl., WO 2010067078 (2010).
Coburn, C. A., McCauley, J. A., Ludmerer, S. W., Liu, K., Vacca, J. P., Wu, H., Hu, B., Soll, R., Sun, F., Wang, X., Yan, M., Zhang, C., Zheng, M., Zhong, B., and Zhu, J., Inhibitors of hepatitis c virus replication. PCT Int. Appl., WO 2010111483 (2010).
Desage-El Murr, M., Cano, C., Golding, B. T., Hardcastle, I. R., Hummersone, M. G., Frigerio, M., Curtin, N. J., Menear, K. A., Richardson, C. J., Smith, G. C. M., and Griffin, R. J., 8-Biarylchromen-4-one inhibitors of the DNA-dependent protein kinase (DNA-PK). Bioorg. Med. Chem. Lett., 18, 4885–4890 (2008).
Griffin, R. J., Fontana, G., Golding, B. T., Guiard, S., Hardcastle, I. R., Leahy, J. J. J., Martin, N., Richardson, C., Rigoreau, L., Stockley, M., and Smith, G. C. M., Selective benzopyranone and pyrimido[2,1-a]isoquinolin-4-one inhibitors of DNA-dependent protein kinase: synthesis, structure-activity studies, and radiosensitization of a human tumor cell line in vitro. J. Med. Chem., 48, 569–585 (2005).
Hollick, J. J., Rigoreau, L., Cano-Soumillac, C., Cockcroft, X.-L., Curtin, N. J., Frigerio, M., Golding, B. T., Guiard, S., Hardcastle, I. R., Hickson, I., Hummersone, M. G., Menear, K. A., Martin, N. M., Matthews, I., Newell, D. R., Ord, R., Richardson, C. J., Smith, G. C. M., and Griffin, R. J., Pyranone, thiopyranone, and pyridone inhibitors of phosphatidylinositol 3-kinase related kinases. Structureactivity relationships for DNA-dependent protein kinase inhibition, and identification of the first potent and selective inhibitor of the ataxia telangiectasia mutated kinase. J. Med. Chem., 50, 1958–1972 (2007).
Jackson, S. P. and Bartek, J., The DNA-damage response in human biology and disease. Nature, 461, 1071–1078 (2009).
Kashishian, A., Douangpanya, H., Clark, D., Schlachter, S. T., Eary, C. T., Schiro, J. G., Huang, H., Burgess, L. E., Kesicki, E. A., and Halbrook, J., DNA-dependent protein kinase inhibitors as drug candidates for the treatment of cancer. Mol. Cancer Ther., 2, 1257–1264 (2003).
Knight, Z. A., Chiang, G. G., Alaimo, P. J., Kenski, D. M., Ho, C. B., Coan, K., Abrahamb, R. T., and Shokat, K. M., Isoform-specific phosphoinositide 3-kinase inhibitors from an arylmorpholine scaffold. Bioorg. Med. Chem., 12, 4749–4759 (2004).
Muci, A. R. and Buchwald, S. L., Practical palladium catalysts for C-N and C-O bond formation. Top. Curr. Chem., 219, 131–209 (2002).
Price, B. D. and Youmell, M. B., The phosphatidylinositol 3-kinase inhibitor wortmannin sensitizes murine fibroblasts and human tumor cells to radiation and blocks induction of p53 following DNA damage. Cancer Res., 56, 246–250 (1996).
Ronald, W. N., Eldon S. P., Daniel, L. C., Peter W. G., Xiaojun, Z., Vladimir, L., Brandon, P., and Luciano, M., Macrocyclic factor V11a inhibitors useful as anticoagulants. PCT Int. Appl., WO2008079836 (2008).
Shinohara, E. T., Geng, L., Tan, J., Chen, H., Shir, Y., Edwards, E., Hallbrook, J., Kesicki, E. A., Kashishian, A., and Hallahan, D. E., DNA-dependent protein kinase is a molecular target for the development of noncytotoxic radiation-sensitizing drugs. Cancer Res., 65, 4987–4992 (2005).
Smith, G. C. and Jackson, S. P., The DNA-dependent protein kinase. Genes Dev., 13, 916–934 (1999).
Stephen, N., Cancer Drug Design and Discovery. Academic press Elsevier, New York, pp. 296–297 (2008).
Sun, L.-Q., He, H., Chen, J., and Wu, Y.-J., Palladiumcatalyzed amination of 3-bromo-4-fluoro-acetophenone. Tetrahedron Lett., 43, 9291–9294 (2002).
Surry, D. S. and Buchwald, S. L., Dialkylbiaryl phosphines in Pd-catalyzed amination: a user’s guide. Chem. Sci., 2, 27–50 (2011).
Verkade, J. G. and Urgaonkar, S., Palladium/proazaphosphatrane-catalyzed amination of aryl halides possessing a phenol, alcohol, acetanilide, amide or an enolizable ketone functional group: efficacy of lithium bis(trimethylsilyl) amide as the base. Adv. Synth. Catal., 346, 611–616 (2004).
Wolfe, J. P. and Buchwald, S. L., Improved functional group compatibility in the palladium-catalyzed amination of aryl bromides. Tetrahedron Lett., 38, 6359–6362 (1997).
Woo, R. A., McLure, K. G., Lees-Miller, S. P., Rancourt, D. E., and Lee, P. W. K., DNA-dependent protein kinase acts upstream of p53 in response to DNA damage. Nature, 394, 700–703 (1998).
Zhang, L., Luo, Y., Fan, R., and Wu, J., Metal- and solventfree conditions for the acylation reaction catalyzed by carbon tetrabromide (CBr4). Green Chem., 9, 1022–1025 (2007)
Author information
Authors and Affiliations
Corresponding author
Additional information
Equally contributed to this work.
Rights and permissions
About this article
Cite this article
Chandra, G., Alexander, V., Lee, H.W. et al. Improved synthesis of a DNA-dependent protein kinase inhibitor IC86621. Arch. Pharm. Res. 35, 639–645 (2012). https://doi.org/10.1007/s12272-012-0407-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12272-012-0407-1